EP2436697 - Chimeric and humanised monoclonal antibodies against interleukin-13 [Right-click to bookmark this link] | Status | Patent revoked Status updated on 26.06.2020 Database last updated on 20.12.2024 | Most recent event Tooltip | 26.06.2020 | Revocation of patent | published on 29.07.2020 [2020/31] | Applicant(s) | For all designated states Glaxo Group Limited 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [2013/18] |
Former [2012/14] | For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN / GB | Inventor(s) | 01 /
Ashman, Claire GlaxoSmithKline Gunnels Wood Road Stevenage, Hertfordshire SG1 2NY / GB | 02 /
Cassidy, Martin John GlaxoSmithKline Gunnels Wood Road Stevenage, Hertfordshire SG1 2NY / GB | 03 /
Ellis, Jonathan Henry GlaxoSmithKline Gunnels Wood Road Stevenage, Hertfordshire SG1 2NY / GB | 04 /
Wattam, Trevor Anthony Kenneth GlaxoSmithKline Gunnels Wood Road Stevenage, Hertfordshire SG1 2NY / GB | [2012/14] | Representative(s) | Chiappinelli, Susan Ann, et al GSK Legal & Compliance - Global Patents 79 New Oxford Street London WC1A 1DG / GB | [N/P] |
Former [2012/14] | Chiappinelli, Susan Ann, et al GlaxoSmithKline Corporate Intellectual Property 980 Great West Road (CN925.1) Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 11181891.0 | 30.06.2005 | [2012/14] | Priority number, date | GB20040014799 | 01.07.2004 Original published format: GB 0414799 | GB20040023675 | 25.10.2004 Original published format: GB 0423675 | [2012/14] | Previously filed application, date | WO2005GB02581 | 30.06.2005 | [2012/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2436697 | Date: | 04.04.2012 | Language: | EN | [2012/14] | Type: | B1 Patent specification | No.: | EP2436697 | Date: | 05.03.2014 | Language: | EN | [2014/10] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 02.03.2012 | Classification | IPC: | C07K16/24, A61P37/02, A61P37/08 | [2012/14] | CPC: |
C07K16/244 (EP,US);
C07K16/24 (KR);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P17/00 (EP);
A61P25/00 (EP);
A61P27/16 (EP);
A61P33/02 (EP);
A61P33/12 (EP);
A61P35/02 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/08 (EP);
C07K16/00 (KR);
A61K2039/505 (EP,US);
C07K2317/24 (EP,US);
C07K2317/34 (EP,US);
C07K2317/56 (EP,US);
C07K2317/565 (EP,US);
C07K2317/73 (EP,US);
C07K2317/76 (EP,US);
Y02A50/30 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2012/14] | Extension states | HR | 19.09.2011 | LV | 19.09.2011 | Title | German: | Chimäre und humanisierte monoklonale Antikörper gegen Interleukin-13 | [2012/14] | English: | Chimeric and humanised monoclonal antibodies against interleukin-13 | [2012/14] | French: | Anticorps monoclonaux, chimériques, humanisés contre l'interleukine 13 | [2012/14] | Examination procedure | 19.09.2011 | Examination requested [2012/14] | 24.09.2012 | Amendment by applicant (claims and/or description) | 02.04.2013 | Communication of intention to grant the patent | 10.07.2013 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 02.12.2013 | Communication of intention to grant the patent | 16.01.2014 | Fee for grant paid | 16.01.2014 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP05757024.4 / EP1802658 | Opposition(s) | Opponent(s) | 01
02.12.2014
05.12.2014
ADMISSIBLE Leeming, John Gerard J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB Opponent's representative J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | 02
05.12.2014
10.12.2014
ADMISSIBLE UCB Biopharma SRL Allée de la Recherche 60 1070 Brussels / BE Opponent's representative J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
Former [2020/08] | |||
Opponent(s) | 01
02.12.2014
05.12.2014
ADMISSIBLE Leeming, John Gerard J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB Opponent's representative J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB | ||
02
05.12.2014
10.12.2014
ADMISSIBLE UCB Biopharma SRL Allée de la Recherche 60 1070 Brussels / BE Opponent's representative J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB | |||
Former [2019/30] | |||
Opponent(s) | 01
02.12.2014
05.12.2014
ADMISSIBLE Leeming, John Gerard J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB Opponent's representative J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | ||
02
05.12.2014
10.12.2014
ADMISSIBLE UCB Biopharma SPRL IP Department 60, Allée de la Recherche 1070 Brussels / BE Opponent's representative J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | |||
Former [2017/28] | |||
Opponent(s) | 01
02.12.2014
05.12.2014
ADMISSIBLE Leeming, John Gerard J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB Opponent's representative J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | ||
02
05.12.2014
10.12.2014
ADMISSIBLE UCB Biopharma SPRL IP Department 60, Allée de la Recherche 1070 Brussels / BE Opponent's representative Blanchard, Amanda Jane UCB Celltech 208 Bath Road Slough, Berkshire SL1 3WE / GB | |||
Former [2015/03] | |||
Opponent(s) | 01
02.12.2014
05.12.2014
ADMISSIBLE Leeming, John Gerard J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB Opponent's representative Roques, Sarah Elizabeth J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | ||
02
05.12.2014
10.12.2014
ADMISSIBLE UCB Biopharma SPRL IP Department 60, Allée de la Recherche 1070 Brussels / BE Opponent's representative Blanchard, Amanda Jane UCB Celltech 208 Bath Road Slough, Berkshire SL1 3WE / GB | |||
Former [2015/02] | |||
Opponent(s) | 01
02.12.2014
Leeming, John Gerard J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB Opponent's representative Roques, Sarah Elizabeth J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | 12.01.2015 | Invitation to proprietor to file observations on the notice of opposition | 16.07.2015 | Reply of patent proprietor to notice(s) of opposition | 31.05.2016 | Date of oral proceedings | 16.06.2016 | Despatch of minutes of oral proceedings | 16.06.2016 | Despatch of communication that the patent will be revoked | 23.07.2019 | Legal effect of revocation of patent [2020/31] | Appeal following opposition | 10.08.2016 | Appeal received No. T1872/16 | 13.10.2016 | Statement of grounds filed | 03.03.2017 | Invitation to file observations in an appeal (Time limit: M04) [2017/09] | 23.07.2019 | Result of appeal procedure: appeal of the proprietor was rejected | 23.07.2019 | Date of oral proceedings | 05.08.2019 | Minutes of the oral proceedings despatched | Fees paid | Renewal fee | 19.09.2011 | Renewal fee patent year 03 | 19.09.2011 | Renewal fee patent year 04 | 19.09.2011 | Renewal fee patent year 05 | 19.09.2011 | Renewal fee patent year 06 | 19.09.2011 | Renewal fee patent year 07 | 31.03.2012 | Renewal fee patent year 08 | 31.03.2013 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 30.06.2005 | AT | 05.03.2014 | BE | 05.03.2014 | CY | 05.03.2014 | CZ | 05.03.2014 | DK | 05.03.2014 | EE | 05.03.2014 | FI | 05.03.2014 | LT | 05.03.2014 | MC | 05.03.2014 | NL | 05.03.2014 | PL | 05.03.2014 | RO | 05.03.2014 | SE | 05.03.2014 | SI | 05.03.2014 | SK | 05.03.2014 | TR | 05.03.2014 | BG | 05.06.2014 | GR | 06.06.2014 | CH | 30.06.2014 | IE | 30.06.2014 | LI | 30.06.2014 | LU | 30.06.2014 | IS | 05.07.2014 | PT | 07.07.2014 | [2016/33] |
Former [2016/32] | HU | 30.06.2005 | |
AT | 05.03.2014 | ||
BE | 05.03.2014 | ||
CY | 05.03.2014 | ||
CZ | 05.03.2014 | ||
DK | 05.03.2014 | ||
EE | 05.03.2014 | ||
FI | 05.03.2014 | ||
LT | 05.03.2014 | ||
MC | 05.03.2014 | ||
NL | 05.03.2014 | ||
PL | 05.03.2014 | ||
RO | 05.03.2014 | ||
SE | 05.03.2014 | ||
SI | 05.03.2014 | ||
SK | 05.03.2014 | ||
BG | 05.06.2014 | ||
GR | 06.06.2014 | ||
CH | 30.06.2014 | ||
IE | 30.06.2014 | ||
LI | 30.06.2014 | ||
LU | 30.06.2014 | ||
IS | 05.07.2014 | ||
PT | 07.07.2014 | ||
Former [2016/28] | AT | 05.03.2014 | |
BE | 05.03.2014 | ||
CY | 05.03.2014 | ||
CZ | 05.03.2014 | ||
DK | 05.03.2014 | ||
EE | 05.03.2014 | ||
FI | 05.03.2014 | ||
LT | 05.03.2014 | ||
MC | 05.03.2014 | ||
NL | 05.03.2014 | ||
PL | 05.03.2014 | ||
RO | 05.03.2014 | ||
SE | 05.03.2014 | ||
SI | 05.03.2014 | ||
SK | 05.03.2014 | ||
BG | 05.06.2014 | ||
GR | 06.06.2014 | ||
CH | 30.06.2014 | ||
IE | 30.06.2014 | ||
LI | 30.06.2014 | ||
LU | 30.06.2014 | ||
IS | 05.07.2014 | ||
PT | 07.07.2014 | ||
Former [2015/24] | AT | 05.03.2014 | |
BE | 05.03.2014 | ||
CY | 05.03.2014 | ||
CZ | 05.03.2014 | ||
DK | 05.03.2014 | ||
EE | 05.03.2014 | ||
FI | 05.03.2014 | ||
LT | 05.03.2014 | ||
MC | 05.03.2014 | ||
NL | 05.03.2014 | ||
PL | 05.03.2014 | ||
RO | 05.03.2014 | ||
SE | 05.03.2014 | ||
SI | 05.03.2014 | ||
SK | 05.03.2014 | ||
BG | 05.06.2014 | ||
CH | 30.06.2014 | ||
IE | 30.06.2014 | ||
LI | 30.06.2014 | ||
LU | 30.06.2014 | ||
IS | 05.07.2014 | ||
PT | 07.07.2014 | ||
Former [2015/21] | AT | 05.03.2014 | |
BE | 05.03.2014 | ||
CY | 05.03.2014 | ||
CZ | 05.03.2014 | ||
DK | 05.03.2014 | ||
EE | 05.03.2014 | ||
FI | 05.03.2014 | ||
LT | 05.03.2014 | ||
MC | 05.03.2014 | ||
NL | 05.03.2014 | ||
PL | 05.03.2014 | ||
RO | 05.03.2014 | ||
SE | 05.03.2014 | ||
SK | 05.03.2014 | ||
BG | 05.06.2014 | ||
CH | 30.06.2014 | ||
IE | 30.06.2014 | ||
LI | 30.06.2014 | ||
LU | 30.06.2014 | ||
IS | 05.07.2014 | ||
PT | 07.07.2014 | ||
Former [2015/20] | AT | 05.03.2014 | |
BE | 05.03.2014 | ||
CY | 05.03.2014 | ||
CZ | 05.03.2014 | ||
DK | 05.03.2014 | ||
EE | 05.03.2014 | ||
FI | 05.03.2014 | ||
LT | 05.03.2014 | ||
MC | 05.03.2014 | ||
NL | 05.03.2014 | ||
PL | 05.03.2014 | ||
RO | 05.03.2014 | ||
SE | 05.03.2014 | ||
SK | 05.03.2014 | ||
BG | 05.06.2014 | ||
CH | 30.06.2014 | ||
LI | 30.06.2014 | ||
LU | 30.06.2014 | ||
IS | 05.07.2014 | ||
PT | 07.07.2014 | ||
Former [2015/09] | AT | 05.03.2014 | |
BE | 05.03.2014 | ||
CY | 05.03.2014 | ||
CZ | 05.03.2014 | ||
DK | 05.03.2014 | ||
EE | 05.03.2014 | ||
FI | 05.03.2014 | ||
LT | 05.03.2014 | ||
MC | 05.03.2014 | ||
NL | 05.03.2014 | ||
PL | 05.03.2014 | ||
RO | 05.03.2014 | ||
SE | 05.03.2014 | ||
SK | 05.03.2014 | ||
BG | 05.06.2014 | ||
LU | 30.06.2014 | ||
IS | 05.07.2014 | ||
PT | 07.07.2014 | ||
Former [2015/08] | AT | 05.03.2014 | |
BE | 05.03.2014 | ||
CY | 05.03.2014 | ||
CZ | 05.03.2014 | ||
DK | 05.03.2014 | ||
EE | 05.03.2014 | ||
FI | 05.03.2014 | ||
LT | 05.03.2014 | ||
NL | 05.03.2014 | ||
PL | 05.03.2014 | ||
RO | 05.03.2014 | ||
SE | 05.03.2014 | ||
SK | 05.03.2014 | ||
BG | 05.06.2014 | ||
IS | 05.07.2014 | ||
PT | 07.07.2014 | ||
Former [2015/02] | AT | 05.03.2014 | |
BE | 05.03.2014 | ||
CY | 05.03.2014 | ||
CZ | 05.03.2014 | ||
EE | 05.03.2014 | ||
FI | 05.03.2014 | ||
LT | 05.03.2014 | ||
NL | 05.03.2014 | ||
PL | 05.03.2014 | ||
RO | 05.03.2014 | ||
SE | 05.03.2014 | ||
SK | 05.03.2014 | ||
BG | 05.06.2014 | ||
IS | 05.07.2014 | ||
PT | 07.07.2014 | ||
Former [2014/50] | AT | 05.03.2014 | |
BE | 05.03.2014 | ||
CY | 05.03.2014 | ||
CZ | 05.03.2014 | ||
EE | 05.03.2014 | ||
FI | 05.03.2014 | ||
LT | 05.03.2014 | ||
NL | 05.03.2014 | ||
PL | 05.03.2014 | ||
RO | 05.03.2014 | ||
SE | 05.03.2014 | ||
SK | 05.03.2014 | ||
BG | 05.06.2014 | ||
IS | 05.07.2014 | ||
Former [2014/49] | AT | 05.03.2014 | |
BE | 05.03.2014 | ||
CY | 05.03.2014 | ||
CZ | 05.03.2014 | ||
EE | 05.03.2014 | ||
FI | 05.03.2014 | ||
LT | 05.03.2014 | ||
RO | 05.03.2014 | ||
SE | 05.03.2014 | ||
BG | 05.06.2014 | ||
IS | 05.07.2014 | ||
Former [2014/48] | AT | 05.03.2014 | |
BE | 05.03.2014 | ||
CY | 05.03.2014 | ||
CZ | 05.03.2014 | ||
EE | 05.03.2014 | ||
FI | 05.03.2014 | ||
LT | 05.03.2014 | ||
SE | 05.03.2014 | ||
BG | 05.06.2014 | ||
Former [2014/46] | AT | 05.03.2014 | |
BE | 05.03.2014 | ||
CY | 05.03.2014 | ||
FI | 05.03.2014 | ||
LT | 05.03.2014 | ||
SE | 05.03.2014 | ||
Former [2014/37] | AT | 05.03.2014 | |
CY | 05.03.2014 | ||
FI | 05.03.2014 | ||
LT | 05.03.2014 | ||
SE | 05.03.2014 | ||
Former [2014/36] | LT | 05.03.2014 | Documents cited: | Search | [A]US6468528 (MAK TAK W [CA], et al) [A] 1-15 * column 2, line 37 - line 43 * * column 5, line 10 - line 50 * * example -; claim - *; | [A]WO03092610 (REGENERON PHARMA [US], et al) [A] 1-15 * paragraph [0006] - paragraph [0010] ** paragraph [0038]; example -; claim - *; | [A]US2003235555 (SHEALEY DAVID [US], et al) [A] 1-15 * paragraph [0015] - paragraph [0020] * * example -; claim - *; | [A] - PUNNONEN ET AL, "The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4<+> or CD8<+> T cells", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, MOSBY - YEARLY BOOK, INC, US, (199712), vol. 100, no. 6, ISSN 0091-6749, pages 792 - 801, XP005138233 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/S0091-6749(97)70276-8 | [AD] - THOMPSON J P ET AL, "MUTANTS OF INTERLEUKIN 13 WITH ALTERED REACTIVITY TOWARD INTERLEUKIN 13 RECEPTORS", JOURNAL OF BIOLOGICAL CHEMISTRY, THE AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, INC, US, (19991015), vol. 274, no. 42, doi:10.1074/JBC.274.42.29944, ISSN 0021-9258, pages 29944 - 29950, XP002948379 [AD] 1-15 * abstract * DOI: http://dx.doi.org/10.1074/jbc.274.42.29944 | by applicant | EP0183070 | US4676980 | EP0244234 | DD266710 | WO9013646 | EP0402226 | WO9302108 | WO9306213 | WO9308829 | WO9313055 | EP0307434 | WO9404690 | EP0612251 | WO9429348 | US5429746 | WO9534534 | US5552438 | US5739277 | WO9830537 | US5807715 | WO9854159 | WO9916766 | WO9947505 | WO9948523 | WO9955369 | WO9962875 | WO0066590 | US6172197 | WO0104118 | WO0110143 | WO0116128 | US6248516 | US6291158 | WO0202565 | WO0226722 | EP0629240 | WO0250021 | WO02066422 | WO02070711 | WO02070490 | WO02076933 | WO03008277 | WO03024439 | WO03059899 | WO03061651 | WO03072539 | WO03082827 | WO03082787 | WO03082280 | WO03086294 | WO03101932 | WO03104195 | WO2004005229 | WO2004009823 | WO2004009016 | WO2004009017 | WO2004018429 | WO2004024728 | WO2004026248 | - EISENMESSER ET AL., J. MOL. BIOL., (2001), vol. 310, no. 1, pages 231 - 241 | - MOY ET AL., J. MOL. BIOL, (2001), vol. 310, no. 1, pages 219 - 230 | - CANNON-CARLSON ET AL., PROTEIN EXPRESSION AND PURIFICATION, (1998), vol. 12, no. 2, pages 239 - 248 | - HILTON ET AL., PNAS, (1996), vol. 93, no. 1, pages 497 - 501 | - CAPUT ET AL., J. BIOL. CHEM., (1996), vol. 271, no. 28, pages 16921 - 16926 | - HERSHEY GK, J.ALLERGY CLIN. IMMUNOL., (2003), vol. 111, no. 4, pages 677 - 690 | - MCKENZIE ET AL., PNAS, (1993), vol. 90, no. 8, pages 3735 - 3739 | - WYNN TA, ANNU. REV. IMMUNOL., (2003), vol. 21, pages 425 - 456 | - BUSSE ET AL., AM. J. RESP. CRIT. CARE MED., (1995), vol. 152, no. 1, pages 388 - 393 | - VERCELLI D, CURR. OPIN. ALLERGY CLIN. IMMUNOL., (2002), vol. 2, no. 5, pages 389 - 393 | - KAZUHIKO ET AL., J. ALLERGY CLIN. IMMUNOL., (2002), vol. 109, no. 6, pages 980 - 987 | - LEE ET AL., J. ASTHMA, (2001), vol. 38, no. 8, pages 665 - 671 | - BERRY ET AL., J ALLERGY CLIN. IMMUNOL, (2004), vol. 114, no. 5, pages 1106 - 1109 | - KROEGEL ET AL., EUR RESPIR. J., (1996), vol. 9, no. 5, pages 899 - 904 | - HUANG ET AL., J. IMMUNOL., (1995), vol. 155, no. 5, pages 2688 - 2694 | - HUMBERT ET AL., J. ALLERGY CLIN. IMMUNOL., (1997), vol. 99, no. 5, pages 657 - 665 | - WILLS-KARP ET AL., SCIENCE, (1998), vol. 282, pages 2258 - 2261 | - GRUNIG ET AL., SCIENCE, (1998), vol. 282, pages 2261 - 2263 | - TAUBE ET AL., J. IMMUNOL., (2002), vol. 169, pages 6482 - 6489 | - BLEASE, J. LMMUNOL, (2001), vol. 166, no. 8, pages 5219 - 5224 | - ZHU ET AL., J. CLIN. INVEST., (1999), vol. 103, no. 6, pages 779 - 788 | - ZHENG ET AL., J. CLIN. INVEST., (2000), vol. 106, no. 9, pages 1081 - 1093 | - J. CLIN. INVEST., (2000), vol. 106, no. 9, pages 1081 - 1093 | - KRAAN ET AL., GENES AND IMMUNITY, (2002), vol. 3, pages 436 - 439 | - MIOTTO ET AL., EUR. RESP. J., (2003), vol. 22, pages 602 - 608 | - BOUTTEN ET AL., THORAX, (2004), vol. 59, pages 850 - 854 | - LI ET AL., J IMMUNOL, (1998), vol. 161, page 7007 | - SIMON ET AL., J ALLERGY CLIN IMMUNOL, (2004), vol. 114, page 887 | - HAMID ET AL., J ALLERGY CLIN IMMUNOL, (1996), vol. 98, page 225 | - ALEKSZA ET AL., BRITISH J DERMATOL, (2002), vol. 147, page 1135 | - OHSHIMA ET AL., PEDIATR RES, (2002), vol. 51, page 195 | - WONGPIYABOVORN ET AL., J DERMATOL SCIENCE, (2003), vol. 33, page 31 | - SCHMID-GRENDELMEIER, J IMMUNOLOGY, (2002), vol. 169, pages 1021 - 1027 | - MISHRA ET AL., GASTROENTEROL, (2003), vol. 125, page 1419 | - KOBAYASHI M ET AL., J. IMMUNOL., (1998), vol. 160, page 5869 | - TERABE ET AL., NAT. IMMUNOL., (2000), vol. 1, page 515 | - KACHA ET AL., J. IMMUNOL., (2000), vol. 165, pages 6024 - 6028 | - ROSENBERG ET AL., J. IMMUNOL., (2000), vol. 165, page 6015 | - CHAOUCHI ET AL., BLOOD, (1996), vol. 87, page 1022 | - KAPP ET AL., J. EXP MED., (1999), vol. 189, page 1939 | - LAI ET AL., J. IMMUNOL., (1999), vol. 162, page 78 | - BILLARD ET AL., EUR CYTOKINE NETW, (1997), vol. 8, page 19 | - SKINNIDER ET AL., BLOOD, (2001), vol. 97, page 250 | - OSHIMA ET AL., CELL IMMUNOL, (2001), vol. 211, page 37 | - TRIEU ET AL., CANCER RESEARCH, (2004), vol. 64, page 3271 | - OHSHIMA ET AL., HISTOPATHOLOGY, (2001), vol. 38, page 368 | - BAMIAS ET AL., GASTROENTEROL, (2005), vol. 128, page 657 | - HELLER ET AL., IMMUNITY, (2002), vol. 17, page 629 | - INOUE ET AL., AM J GASTROENTEROL, (1999), vol. 94, page 2441 | - AKIHO ET AL., AM J PHYSIOL GASTROINTEST LIVER PHYSIOL, (2005), vol. 288, page 619 | - SKOV ET AL., AM J PATHOL, (1997), vol. 15, page 675 | - HUANG ET AL., J INVEST DERMAL, (2001), vol. 116, page 305 | - CANCINO-DIAZ ET AL., J INVEST DERMATO1, (2002), vol. 119, page 1114 | - SPADARO ET AL., ANN RHEUM DIS, (2002), vol. 61, page 174 | - JORDAN ET AL., J IMMUNOL METHODS, (2002), vol. 260, page 1 | - JORDAN ET AL., BLOOD, (2004), vol. 103, page 717 | - COOPER, DIABETOLOGIA, (2001), vol. 44, page 1957 | - WOLF, EUR J CLIN INVEST, (2004), vol. 34, no. 12, page 785 | - LEE ET AL., J. EXP. MED., (2001), vol. 194, page 809 | - ZHU ET AL., J. CLIN. INVEST., (1999), vol. 103, page 779 | - WYNN TA, NAT. REV. IMMUNOL., (2004), vol. 4, pages 583 - 594 | - JAKUBZICK ET AL., AM. J. PATHOL., (2004), vol. 164, no. 6, pages 1989 - 2001 | - JAKUBZICK ET AL., IMMUNOL. RES., (2004), vol. 30, no. 3, pages 339 - 349 | - JAKUBZICK ET AL., J. CLIN. PATHOL., (2004), vol. 57, pages 477 - 486 | - HASEGAWA ET AL., J. RHEUMATOL., (1997), vol. 24, pages 328 - 332 | - RICCIERI ET AL., CLIN. RHEUMATOL, (2003), vol. 22, pages 102 - 106 | - ORIENTE ET AL., J. PHARMACOL. EXP. THER., (2000), vol. 292, pages 988 - 994 | - JINNIN ET AL., J. BIOL. CHEM, (2004), vol. 279, pages 41783 - 41791 | - DOUCET ET AL., INT. IMMUNOL., (1998), vol. 10, no. 10, pages 1421 - 1433 | - ZHOU ET AL., AM. J. PHYSIOL. CELL PHYSIOL., (2005), vol. 288, pages C435 - C442 | - BELPERIO ET AL., AM. J. RESPIR. CELL MOL. BIOL., (2002), vol. 27, pages 419 - 427 | - KOLODSICK ET AL., J. IMMUNOL., (2004), vol. 172, pages 4068 - 4076 | - LEE ET AL., J. EXP. MED., (2001), vol. 194, pages 809 - 821 | - GHARAEE-KERMANI ET AL., CYTOKINE, (2001), vol. 15, pages 138 - 147 | - IZBICKI ET AL., AM. J. PHYSIOL. LUNG CELL MOL. PHYSIOL, (2002), vol. 283, no. 5, pages L1110 - L1116 | - JAKUBZICK ET AL., J. IMMUNOL, (2003), vol. 171, pages 2684 - 2693 | - JAKUBZICK ET AL., AM. J. PATHOL., (2003), vol. 162, pages 1475 - 1486 | - CHIARAMONTE ET AL., J. CLIN. INVEST., (1999), vol. 104, pages 777 - 785 | - BLEASE ET AL., J. IMMUNOL., (2001), vol. 166, page 5219 | - KUMAR ET AL., CLIN. EXP. ALLERGY, (2002), vol. 32, page 1104 | - CHIARAMONTE ET AL., J. CLIN. INVEST., (1999), vol. 104, page 777 | - CHIARAMONTE ET AL., HEPATOLOGY, (2001), vol. 34, page 273 | - HERRICK ET AL., THE JOURNAL OF IMMUNOLOGY, (2003), vol. 170, pages 2488 - 2495 | - THOMPSON J.P; DEBINSKI W, J.BIOL.CHEM, (1999), vol. 24, no. 42, pages 29944 - 29950 | - CHOTHIA ET AL., "Conformations of immunoglobulins hyperVariable regions", NATURE, (1989), vol. 342, doi:doi:10.1038/342877a0, pages 877 - 883, XP002030586 DOI: http://dx.doi.org/10.1038/342877a0 | - KOZBOR, J.IMMUNOL, (1984), vol. 133, page 3001 | - BRODEURI, Monoclonal Antibody Production Techniques and Applications, MARCEL DEKKER INC, (1987), pages 51 - 63 | - WINTER G, ANNU.REV.LMMUNOL, (1994), vol. 12, pages 433 - 455 | - GREEN LL, J.LMMUNOL.METHODS, (1999), vol. 231, pages 11 - 23 | - TOMIZUKA K, PNAS, (2000), vol. 97, pages 722 - 727 | - FISHWILD D.M, NATURE BIOTECHNOL., (1996), vol. 14, pages 845 - 851 | - MENDEZ MJ, NATURE GENETICS, (1997), vol. 15, pages 146 - 156 | - EREN R ET AL., IMMUNOLOGY, (1998), vol. 93, pages 154 - 161 | - BABCOOK ET AL., PNAS, (1996), vol. 93, pages 7843 - 7848 | - MCCAFFERTY, NATURE, (1990), vol. 348, pages 552 - 553 | - GRIFFITHS AD ET AL., EMBO, (1994), vol. 13, pages 3245 - 3260 | - MARKS, J.MOI.BIO., (1991), vol. 222, pages 581 - 597 | - MARKS, BIO/TECHNOL, (1992), vol. 10, pages 779 - 783 | - WATERHOUSE, NUD.ACIDS RES, (1993), vol. 21, pages 2265 - 2266 | - MORRISON, PNAS, (1984), vol. 81, page 6851 | - JONES ET AL., NATURE, (1986), vol. 321, pages 522 - 525 | - VERHOEYEN M ET AL., SCIENCE, (1988), vol. 239, pages 1534 - 1536 | - QUEEN C ET AL., PNAS, (1989), vol. 86, pages 10,029 - 10,033 | - CO, METAL, NATURE, (1991), vol. 351, pages 501 - 502 | - PADLAN E.A., MOL.LMMUNOL., (1991), vol. 28, pages 489 - 498 | - PEDERSEN J.T. ET AL., J.MOL.BIOL., (1994), vol. 235, pages 959 - 973 | - MARK G.E. ET AL., Handbook of Experimental Pharmacology vol. 113: The pharmacology of monoclonal Antibodies, SPRINGER-VERLAG, (1994), vol. 113, pages 105 - 134 | - MILLSTEIN ET AL., NATURE, (1983), vol. 305, pages 537 - 539 | - TRAUNECKER ET AL., EMBO, (1991), vol. 10, pages 3655 - 3659 | - SURESH ET AL., METHODS IN ENZYMOLOGY, (1986), vol. 121, page 210 | - BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426 | - HUSTON ET AL., PNAS, vol. 85, pages 5879 - 5883 | - GLOCKSHUBER ET AL., BIOCHEMISTRY, (1990), vol. 29, pages 1362 - 1367 | - ZHU ET AL., PROTEIN SCI., (1997), vol. 6, pages 781 - 788 | - WHITLOW ET AL., METHODS COMPANION METHODS ENZYMOL, (1991), vol. 2, pages 97 - 105 | - HUSTON ET AL., INT.REV.LMMUNOL, (1993), vol. 10, pages 195 - 217 | - ADAMS ET AL., CAN.RES, (1993), vol. 53, pages 4026 - 4034 | - MCCARTNEY ET AL., PROTEIN ENG., (1995), vol. 8, pages 301 - 314 | - KIPRIYANOV ET AL., CELL. BIOPHYS, (1995), vol. 26, pages 187 - 204 | - HOLLIGER ET AL., PNAS, (1993), vol. 90, pages 6444 - 6448 | - KORTT ET AL., PROTEIN ENG, (1997), vol. 10, pages 423 - 433 | - LE GALL, FEBS LETT, (1999), vol. 453, pages 164 - 168 | - PACK ET AL., BIOCHEMISTRY, (1992), vol. 31, pages 1579 - 1584 | - HU ET AL., CANCER RES., (1996), vol. 56, pages 3055 - 3061 | - KURUCZ ET AL., J.IMMOL., (1995), vol. 154, pages 4576 - 4582 | - KIPRIYANOV ET AL., INT.J.CAN, (1998), vol. 77, pages 763 - 772 | - KONTERMANN ET AL., J.IMMUNOL.MELHODS, (1999), vol. 226, pages 179 - 188 | - COLOMA ET AL., NATURE BIOTECHNOL., (1997), vol. 15, pages 159 - 163 | - ALT, FEBS LETT, (1999), vol. 454, pages 90 - 94 | - MULLER ET AL., FEBS LETT, (1998), vol. 432, pages 45 - 49 | - KIPRIYANOV, J.MOL.BIOL., (1999), vol. 293, pages 41 - 56 | - SHALABY ET AL., J.EXP.MED., (1992), vol. 175, pages 217 - 225 | - KOSTELNY ET AL., J.LMMUNOL., (1992), vol. 148, pages 1547 - 1553 | - SHIELDS ET AL., J.BIOL.CHEM, (2001), vol. 276, pages 6591 - 6604 | - JUNGHANS R.P, IMMUNOL.RES, (1997), vol. 16, pages 29 - 57 | - GHETIE ET AL., ANNU.REV.LMMUNOL., (2000), vol. 18, pages 739 - 766 | - BOYD ET AL., MOL.LMMUNOL., (1996), vol. 32, pages 1311 - 1318 | - RAJU ET AL., BIOCHEMISTRY, (2001), vol. 40, pages 8868 - 8876 | - ZHANG ET AL., SCIENCE, (2004), vol. 303, page 371 | - SEARS ET AL., SCIENCE, (2001), vol. 291, page 2344 | - WACKER, SCIENCE, (2002), vol. 298, page 1790 | - DAVIS ET AL., CHEM.REV., (2002), vol. 102, page 579 | - HANG ET AL., ACC.CHEM.RES, (2001), vol. 34, page 727 | - KOUMENIS I.L. ET AL., INT.J.PHARMACEUT., (2000), vol. 198, pages 83 - 95 | - POLLOCK ET AL., J.IMMUNOL.METHODS, (1999), vol. 231, pages 147 - 157 | - MORROW KJJ, GENET.ENG.NEWS, (2000), vol. 20, pages 1 - 55 | - DORAN PM, CURR.OPINION BIOTECHNOL., (2000), vol. 11, pages 199 - 204 | - MA JK-C, NAT.MED., (1998), vol. 4, pages 601 - 606 | - BAEZ J ET AL., BIOPHARM, (2000), vol. 13, pages 50 - 54 | - STOGER E ET AL., PLANT MOL.BIOL., (2000), vol. 42, pages 583 - 590 | - STINCHCOMB ET AL., NATURE, (1979), vol. 282, page 38 | - PENG ET AL., J.BIOTECHNOL., (2004), vol. 108, pages 185 - 192 | - SANCHEZ ET AL., J.BIOTECHNOL., (1999), vol. 72, pages 13 - 20 | - CUPIT PM, LETT APPL MICROBIOL, (1999), vol. 29, pages 273 - 277 | - DRAPEAU ET AL., CYTOTECHNOLOGY, (1994), vol. 15, pages 103 - 109 | - KEEN ET AL., CYTOTECHNOLOGY, (1995), vol. 17, pages 153 - 163 | - SCHARFENBERG K ET AL., Animal Cell technology: Developments towards the 21st century, KLUWER ACADEMIC PUBLISHERS, (1995), pages 619 - 623 | - LANDELLS, L.J ET AL., EUR RESP J, (19980919), vol. 12, no. 28 | - FUJI, K. ET AL., J PHARMACOL EXP THER, (1998), vol. 284, no. 1, page 162 | - BUSSE WW ET AL., J ALLERGY CLIN. IMMUNOL, (2000), vol. 106, pages 1033 - 1042 | - BARNES PJ, EUR RESPIR J, (1998), vol. 12, pages 1208 - 1218 | - AYRES JG ET AL., THORAX, (1998), vol. 58, pages 315 - 321 | - WOODCOCK AJ, EUR RESPIR J, (1993), vol. 6, pages 743 - 747 | - JONES ST; BENDIG MM, BIO/TECHNOLOGY, (1991), vol. 9, pages 88 - 89 | - STEMMER WP ET AL., GENE, (1995), vol. 164, no. 1, pages 49 - 53 | - ERTL PF ET AL., METHODS, (2003), vol. 31, pages 199 - 206 | - PATTERSON R ET AL., TRANS. ASSOC. AM. PHYSICIANS, (1980), vol. 93, pages 317 - 325 | - PATTERSON R ET AL., J. LAB. CLIN. MED., (1983), vol. 101, pages 864 - 872 | - MAUSER P ET AL., AM. J. RESP. CRIT. CARE MED., (1995), vol. 204, pages 467 - 472 | - EVANOFF H ET AL., IMMUNOLOGIC INVESTIGATION, (1992), vol. 21, page 39 | US20030487981 | US20030511009 | WO2003EP14867 | WO2004EP05494 |